Viviam Dante
Nurse Practitioner · Muscle Shoals, ALNPI 1952988495
Payments from drug & device makers
Across 268 payments — averaging $15.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$493
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$482
- Scilex Pharmaceuticals Inc.$192
- Exact Sciences$173
- Novo Nordisk$161
- plus $1K from 22 others
What the payments were for
- Food & beverage$4,093100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 105 | $1,362 |
| Lilly USA, LLC | 36 | $493 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 35 | $482 |
| Scilex Pharmaceuticals Inc. | 11 | $192 |
| Exact Sciences | 7 | $173 |
| Novo Nordisk | 9 | $161 |
| Idorsia Pharmaceuticals US Inc | 8 | $142 |
| Indivior Inc. | 6 | $128 |
| Gilead | 3 | $123 |
| AstraZeneca | 7 | $112 |
| Pfizer | 6 | $109 |
| Amgen | 6 | $103 |
| Axsome Therapeutics, Inc. | 4 | $67 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $62 |
| Bayer | 3 | $60 |
| Braeburn Inc. | 2 | $48 |
| GSK | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Supernus Pharmaceuticals, Inc. | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Almatica Pharma LLC | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Tolmar, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
How this compares
$4,093 in reported general payments places this provider in the 90th percentile of 1,505 nurse practitioner providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 46 | $71,644 |
| TrulicityDulaglutide | 17 | $38,258 |
| VraylarCariprazine Hcl | 13 | $22,614 |
| FarxigaDapagliflozin Propanediol | 13 | $17,414 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $10,938 |
| LinzessLinaclotide | 13 | $10,814 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 23 | $4,842 |
| Pregabalin | 28 | $1,868 |
| Celecoxib | 36 | $1,175 |
| Diclofenac Sodium | 14 | $856 |
| Duloxetine Hcl | 42 | $653 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 30 | $643 |
| Lisinopril | 40 | $446 |
| Levothyroxine Sodium | 38 | $311 |
| Atorvastatin Calcium | 37 | $302 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $493 | $109,90263 claims |
| AbbVieVraylar, Linzess | $1,362 | $33,42926 claims |
| AstraZenecaFarxiga | $112 | $17,41413 claims |
| GSKTrelegy Ellipta | $47 | $10,93817 claims |
| Almatica Pharma LLCSertraline Hcl | $21 | $13924 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,505 nurse practitioner providers in Alabama.
Other nurse practitioner in Muscle Shoals
- Erin TannerAlabaster$141K
- Ardie Pack MabienMobile$126K
- Ginger McDanielBirmingham$27K
- Audrey MorganMontgomery$24K
- Hollie CrutchfieldDothan$22K
- Leah GravesBirmingham$21K
- Lauren DowneyBirmingham$19K
- Ashley HodgensMontgomery$19K
- Lisa PeoplesBirmingham$17K
- Samantha WeaverBirmingham$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.